Related Experiment Videos
Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA
P Sander1, T Prammananan, E C Böttger
1Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.
Molecular Microbiology
|December 1, 1996
Summary
Researchers created a single-operon Mycobacterium smegmatis strain to study drug-resistant ribosomal RNA (rRNA) mutations. This method overcomes challenges in isolating recessive mutations, enabling new insights into rRNA structure and function.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Eubacterial organisms typically possess multiple ribosomal RNA (rRNA) operons.
- The presence of multiple rRNA operons complicates the isolation of recessive rRNA mutations due to recessivity, hindering studies on drug resistance.
- Developing methods to study single rRNA operons is crucial for understanding ribosome function and developing novel antimicrobial strategies.
Purpose of the Study:
- To construct a Mycobacterium smegmatis mutant with a single functional rRNA operon.
- To establish a system for isolating and characterizing drug-resistant rRNA mutants.
- To investigate the potential of this system for studying rRNA structure and function.
Main Methods:
- Gene-inactivation techniques were used to create a single rRNA operon mutant.
- Homologous recombination was employed to replace the chromosomal rRNA operon with a plasmid-borne rDNA segment containing resistance markers.
- Allelic exchange experiments were performed to validate the drug resistance phenotype.
Main Results:
- A viable Mycobacterium smegmatis strain with a single functional rRNA operon was successfully constructed.
- The single-operon system enabled the isolation of rRNA mutants exhibiting a drug-resistant phenotype, overcoming the issue of recessivity.
- Allelic exchange experiments confirmed that the identified rRNA mutation confers in vivo drug resistance.
Conclusions:
- The developed single-rRNA operon system in Mycobacterium smegmatis is effective for isolating drug-resistant rRNA mutants.
- This system circumvents the challenge of recessivity associated with multiple rRNA operons.
- The platform offers significant potential for advancing research into ribosomal RNA structure, function, and the development of novel therapeutics.